A recent study suggested that DSG2 could promote the carcinogenesis and progression of squamous cell carcinoma by enhancing exosome synthesis and secretion.[71] Consequently, these chromosomal rearrangements associated with differential gene expression may serve as prognostic markers and potential therapeutic targets for PDAC in the future. Here, DSG2 is linked to squamous cell carcinoma.